Literature DB >> 7247363

In vitro susceptibility of Salmonella to various antimicrobial agents, including a new cephalosporin, Ro 13-9904.

P Y Chau, W S Ng, J Ling, K Arnold.   

Abstract

The in vitro susceptibility of 363 strains of Salmonella isolated in Honk Kong to various antimicrobial drugs was tested, and the minimum inhibitory concentrations of ampicillin, mecillinam, and six cephalosporins (cephalexin, cephradine, cefamandole, cefoxitin, cefuroxime, and Ro 13-9904) for these strains were determined by an agar dilution method. Although strains of the typhoid and paratyphoid group remained susceptible to most antibiotics tested, many strains of the gastroenteric group of salmonellae were found to be resistant to multiple antibiotics, including ampicillin, chloramphenicol, and, occasionally, trimethoprim. Mecillinam and cefamandole, although active against most of the Salmonella strains tested, were shown to be less active against ampicillin-resistant strains. By contrast, Ro 13-9904 exhibited remarkably uniform and high activity against all the Salmonella strains tested, irrespective of their ampicillin resistance.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7247363      PMCID: PMC181348          DOI: 10.1128/AAC.19.1.8

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  13 in total

1.  The problem and implications of chloramphenicol resistance in the typhoid bacillus.

Authors:  E S Anderson
Journal:  J Hyg (Lond)       Date:  1975-04

2.  In vitro antibiotic susceptibility of salmonellae.

Authors:  F Barros; O M Korzeniowski; M A Sande; K Martins; L C Santos; H Rocha
Journal:  Antimicrob Agents Chemother       Date:  1977-06       Impact factor: 5.191

3.  Chloramphenicol-resistant typhoid fever in Vietnam associated with R factor.

Authors:  T Butler; N N Linh; K Arnold; M Pollack
Journal:  Lancet       Date:  1973-11-03       Impact factor: 79.321

4.  Antimicrobial resistance and R-factor transfer among isolates of Salmonella in the northeastern United States: a comparison of human and animal isolates.

Authors:  H C Neu; C E Cherubin; E D Longo; B Flouton; J Winter
Journal:  J Infect Dis       Date:  1975-12       Impact factor: 5.226

5.  Multiple antibiotic resistance among salmonellae in India.

Authors:  K B Sharma; M B Bhat; A Pasricha; S Vaze
Journal:  J Antimicrob Chemother       Date:  1979-01       Impact factor: 5.790

6.  Resistance to chloramphenicol and ampicillin Salmonella johannesburg in Hong Kong: observations over a five-year period 1973-1977.

Authors:  P Y Chau; W T Wong; Y P Fok
Journal:  J Hyg (Lond)       Date:  1978-12

7.  Drug resistance and R plasmids in Salmonella typhi isolated in Korea.

Authors:  D Chun; S Y Seol; D T Cho; R Tak
Journal:  Antimicrob Agents Chemother       Date:  1977-02       Impact factor: 5.191

8.  Salmonella gastroenteritis in Hong Kong--a clinical review of 200 patients.

Authors:  W Y Lui; W K Chang; T F Fok; C H Teoh-Chan
Journal:  J Trop Med Hyg       Date:  1979-03

9.  Salmonella serotypes, Salmonella typhi phage types, and anti-microbial resistance at the University Hospital of the West Indies, Jamaica.

Authors:  G L French; S D King; P S Louis
Journal:  J Hyg (Lond)       Date:  1977-08

10.  Salmonella typhi resistant to chloramphenicol, ampicillin, and other antimicrobial agents: strains isolated during an extensive typhoid fever epidemic in Mexico.

Authors:  J Olarte; E Galindo
Journal:  Antimicrob Agents Chemother       Date:  1973-12       Impact factor: 5.191

View more
  9 in total

1.  Pharmacokinetic characteristics of intravenous ceftriaxone in normal adults.

Authors:  A A Pollock; P E Tee; I H Patel; J Spicehandler; M S Simberkoff; J J Rahal
Journal:  Antimicrob Agents Chemother       Date:  1982-11       Impact factor: 5.191

2.  Ceftriaxone: in vitro studies and clinical evaluation.

Authors:  J W Gnann; W E Goetter; A M Elliott; C G Cobbs
Journal:  Antimicrob Agents Chemother       Date:  1982-07       Impact factor: 5.191

Review 3.  Fluoroquinolones in the treatment of typhoid fever and the carrier state.

Authors:  I Zavala Trujillo; C Quiroz; M A Gutierrez; J Arias; M Renteria
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-04       Impact factor: 3.267

Review 4.  Clinical pharmacokinetics of ceftriaxone.

Authors:  J H Yuk; C H Nightingale; R Quintiliani
Journal:  Clin Pharmacokinet       Date:  1989-10       Impact factor: 6.447

5.  Comparative efficacies of ceftriaxone, moxalactam, and ampicillin in experimental Salmonella typhimurium infection.

Authors:  P A Anton; J A Kemp; T Butler; M R Jacobs
Journal:  Antimicrob Agents Chemother       Date:  1982-08       Impact factor: 5.191

6.  In vivo activity of ceftriaxone (Ro 13-9904), a new broad-spectrum semisynthetic cephalosporin.

Authors:  G Beskid; J G Christenson; R Cleeland; W DeLorenzo; P W Trown
Journal:  Antimicrob Agents Chemother       Date:  1981-08       Impact factor: 5.191

7.  Ceftriaxone therapy in bacteremic typhoid fever.

Authors:  T Y Ti; E H Monteiro; S Lam; H S Lee
Journal:  Antimicrob Agents Chemother       Date:  1985-10       Impact factor: 5.191

8.  Highly selective synthesis of D-amino acids via stereoinversion of corresponding counterpart by an in vivo cascade cell factory.

Authors:  Dan-Ping Zhang; Xiao-Ran Jing; Lun-Jie Wu; An-Wen Fan; Yao Nie; Yan Xu
Journal:  Microb Cell Fact       Date:  2021-01-09       Impact factor: 5.328

9.  Successful treatment of typhoid fever with a single dose of ceftriaxone for one or two days.

Authors:  H Y Chung; M W Kang; W S Shin; S K Kim
Journal:  Korean J Intern Med       Date:  1987-01       Impact factor: 2.884

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.